Commercialization Of Biospecimens
Commercialization of Biospecimens is the process by which human biological samples and their associated data are utilized for profit-driven research, development, or product creation within the biobanking context, distinguished from non-commercial uses by the pursuit of financial gain and proprietary control.
52
Publications
2.2K
Citations
217
Authors
139
Institutions
Publications per year
2017–2026
19
Parents
52
1–5 of 52
217
4
h-index
3
h-index
2
h-index
2
h-index
2
h-index
1–5 of 217
139

BC Cancer Agency
Vancouver, Canada
4 h-index
14 publications
603 citations

University of Tasmania
Hobart, Australia
3 h-index
6 publications
429 citations

University of Naples Federico II
Naples, Italy
3 h-index
5 publications
202 citations

University of Nottingham
Nottingham, United Kingdom
2 h-index
3 publications
35 citations

University of Alabama at Birmingham
Birmingham, United States
2 h-index
4 publications
64 citations
Swinburne University of Technology
Melbourne, Australia
2 h-index
3 publications
183 citations

Medical University of Graz
Graz, Austria
2 h-index
5 publications
124 citations
Inserm
Paris, France
2 h-index
4 publications
68 citations
1–8 of 139
10 publications · 268 citations
10
h-index
2 publications · 139 citations
2
h-index
1 publications · 53 citations
1
h-index
1 publications · 34 citations
1
h-index
1 publications · 14 citations
1
h-index
1–5